MAPK9 signaling pathway is reported to have regulatory roles in non-small cell lung cancer, bladder cancer, cholangiocarcinoma and other cancers (Hao et al., 2021; Huang et al., 2021; Teng et al., 2021). This evidence concerns the gene MAPK9 and cholangiocarcinoma.